Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is N/A as of Tuesday, October 6, 2026.
DEBT TO ASSETS RATIO
N/A
Freenome, Inc.
Market Cap
$137.29M
Debt to Assets Ratio
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO |
|---|---|---|
| Freenome, Inc. (FRNM) | $137.29M | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | 0.36% |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | 0.00% |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | 0.20% |
| Health Catalyst, Inc. (HCAT)vs › | $130.05M | 0.47% |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | 0.02% |
| Cibus, Inc. (CBUS)vs › | $128.24M | 0.10% |
| Immuneering Corporation (IMRX)vs › | $146.66M | 0.02% |
| enGene Holdings Inc. (ENGN)vs › | $125.27M | 0.12% |
| Codexis, Inc. (CDXS)vs › | $149.51M | 0.60% |
Debt/Assets
N/A
Debt/Equity
N/A
Current Ratio
N/A
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
